E-LIB Suche - Ergebnisse für: Huang, Dingzhi

1

Garsorasib in patients with KRASG12C-mutated non-small-cell..:

Li, Ziming ; Dang, Xiaomin ; Huang, Dingzhi...
The Lancet Respiratory Medicine. 12 (2024) 8 - p. 589-598 , 2024

Link: https://doi.org/10.1016/..

2

Rechallenge of immune checkpoint inhibitors in advanced non..:

Lin, Gen ; Wang, Zhijie ; Chu, Qian...
Thoracic Cancer. , 2024

Link: https://doi.org/10.1111/..

3

Myeloprotection with trilaciclib in Chinese patients with e..:

Cheng, Ying ; Wu, Lin ; Huang, Dingzhi...
Lung Cancer. 188 (2024) - p. 107455 , 2024

Link: https://doi.org/10.1016/..

4

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monothera..:

Zhou, Qing ; Meng, Xiangjiao ; Sun, Longhua...
Journal of Thoracic Oncology. , 2024

Link: https://doi.org/10.1016/..

5

AKR1C3 promotes progression and mediates therapeutic resist..:

Liu, Wenting ; Li, Guoli ; Huang, Dingzhi.
Translational Oncology. 47 (2024) - p. 102027 , 2024

Link: https://doi.org/10.1016/..

6

PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy respons..:

Chen, Xiuqiong ; Zhou, Jing ; Wang, Youhui...
Oncogene. , 2024

Link: https://doi.org/10.1038/..

7

Pretreatment pulmonary tumor necrosis is a promising progno..:

Zhong, Qiaofeng ; Zhang, Longfeng ; Wu, Lin...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

8

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plu..:

Cheng, Ying ; Fan, Yun ; Zhao, Yanqiu...
Journal of Thoracic Oncology. 19 (2024) 7 - p. 1073-1085 , 2024

Link: https://doi.org/10.1016/..

9

Comprehensive analysis the prognostic and immune characteri..:

Liu, Wenting ; Du, Qingwu ; Mei, Ting...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

10

Quantification of preexisting lung ground glass opacities o..:

Wang, Xinyue ; Zhao, Jinkun ; Mei, Ting...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

11

PIM1 kinase promotes EMT-associated osimertinib resistance ..:

Zhou, Jing ; Wang, Xinyue ; Li, Zhaona...
Cell Death & Disease. 15 (2024) 9 - p. , 2024

Link: https://doi.org/10.1038/..

12

Tunlametinib (HL-085) plus vemurafenib in patients with adv..:

Shi, Yuankai ; Han, Xiaohong ; Zhao, Qian...
Experimental Hematology & Oncology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

13

SAFFRON-103: a phase 1b study of the safety and efficacy of..:

Zhao, Jun ; Yu, Xinmin ; Huang, Dingzhi...
Journal for ImmunoTherapy of Cancer. 11 (2023) 2 - p. e006055 , 2023

Link: https://doi.org/10.1136/..

14

First-line atezolizumab monotherapy versus single-agent che..:

Lee, Siow Ming ; Schulz, Christian ; Prabhash, Kumar...
The Lancet. 402 (2023) 10400 - p. 451-463 , 2023

Link: https://doi.org/10.1016/..

15

Clinical definition of secondary resistance to immunotherap..:

Huang, Dingzhi ; Lin, Gen ; Chu, Qian...
Thoracic Cancer. 14 (2023) 34 - p. 3421-3429 , 2023

Link: https://doi.org/10.1111/..